Minimally invasive early multi-cancer detection blood test for dogs based on Next-Generation-Sequencing and AI.

#earlycancerdetection #petcare #ai

What our founder think:

We are impacting the world by….

…revolutionizing early cancer detection for your best friend.

We are convinced that the world in the next 5 years …

…will transform pet health through advances in AI and sequencing.

REAKTOR.BERLIN enables us to…

…access a large network to challenge us and make us grow


Cancer is the leading cause of death in adult dogs, affecting 1 in 3 dogs over their lifetime. Early detection is challenging due to current diagnostic methods, which mainly rely on physical exams and imaging, often identifying cancer too late for effective treatment. Testblu diagnostics has developed a minimally invasive, easy-to-use blood test that combines Next Generation Sequencing and AI. This innovative test can potentially detect multiple types of cancer at early stages, improving treatment outcomes and reducing stress for both dogs and their owners.

Founder team

Laurin Siefermann

Laurin Siefermann

Co-Founder: Business focused

Shahab Matin

Co-Founder: Tech focus


Biotech, Petcare

Find out more